Enlivex Ltd. (ENLV)

NASDAQ: ENLV · USD

$2.60

-0.10 (-3.7%)· Recorded snapshot

Market cap	3.2M
Net income (ttm)	3.2B
EPS (ttm)	$4,469
Shares out	1.2M
P/E (trailing)	0.0x
Volume	34,740
Beta	1.41

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): 3.2B
EPS (ttm): $4,469
P/E (trailing): 0.0x
Market cap: 3.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E0

P25 n/aP50 n/aP75 n/a

ROE162.9

P25 n/aP50 n/aP75 n/a

ROIC-0.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ENLV indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

USD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001596812
Company name	Enlivex Ltd.
Country	Israel
Country code	US
CUSIP number	M20156127
Earnings date	2026-11-13
Earnings time	amc
Employees	34
Employees change	-37
Employees growth	-52.11%
Enterprise value	$15.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
Industry	Biotechnology
IPO date	1995-12-12
Is primary listing	Yes
Is SPAC	No
ISIN number	IL0011319527
Last 10-K release date	2008-03-17
Last earnings date	2026-09-25
Last refreshed	2026-10-28
Last stock split date	2026-10-27
Last stock split type	Reverse
Market cap	$3.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$2.60
Price currency	USD
Sector	Healthcare
SIC code	6199
Stock price date	2026-10-28
Symbol	ENLV
Website	https://www.enlivex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	171,891.85%
EV/Earnings	0x
FCF / EV yield	-101.18%
FCF yield	-463.36%
Graham number	19303.30734
Graham upside	714,837.31%
P/B ratio	0x
P/E ratio	0x
Price / tangible book value	0x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Effective tax rate	23.32%
Profit per employee	$93.8M
Profitable quarters	2
Profitable years	1
ROA	-0.61%
ROA (5Y)	-19.48%
ROCE	-0.5%
ROE	162.86%
ROE (5Y)	-12.89%
ROIC	-0.64%
ROIC (5Y)	-361.79%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	80.28%
EPS growth quarters	9
EPS growth years	3
Net income growth (QoQ)	94.11%
Net income growth quarters	9
Net income growth years	3
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-38,000
Depreciation and amortization	$278,000
EBIT	$-24.2M
EBITDA	$-23.9M
EPS	$4,469.19
FCF per share	$-12.51
Financing cash flow	$33.3M
Free cash flow	$-15.6M
Free cash flow minus SBC	$-23.5M
Income taxes	$969.9M
Investing cash flow	$-14.1M
Net borrowing	$17.9M
Net cash flow	$3.7M
Net income	$3.2B
Operating cash flow minus SBC	$-23.5M
Operating income	$-24.2M
Stock-based compensation	$7.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$3,705.55
Debt / equity	0
Long-term assets	$1.1B
Long-term liabilities	$970.3M
Net cash (debt)	$-12M
Net cash / market cap	-357.96%
Net debt / equity	0
Piotroski F-Score	2
Property, plant and equipment	$838,000
Shareholders' equity	$3.9B
Tangible book value	$3.9B
Tangible book value per share	$3,705.55
Total assets	$4.9B
Total cash	$5.5M
Total debt	$17.5M
Total liabilities	$1B
WACC	1.93%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$3.8B
Current liabilities	$31.4M
Current ratio	119.39
Net working capital	$3.7B
Quick ratio	0.19
Working capital	$3.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-649.71%
Dividend yield	0%
Shareholder yield	-649.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$101.44
1D price change	-3.7%
1M price change	-72.73%
1M total return	-72.73%
1W price change	-27.16%
1W total return	-27.16%
1Y price change	-98.99%
1Y return CAGR	-99%
1Y total return	-98.99%
20-day SMA	$3.98
200-day SMA	$141.52
3M price change	-96.18%
3M total return	-96.18%
3Y price change	-99.18%
3Y return CAGR	-79.85%
3Y total return	-99.18%
50-day SMA	$11.51
50-day SMA vs 200-day SMA	50under200
52-week high	$434.40
52-week high date	2025-11-24
52-week low	$2.22
52-week low date	2026-10-27
5Y price change	-99.87%
5Y return CAGR	-73.44%
5Y total return	-99.87%
6M price change	-98.77%
6M total return	-98.77%
All-time high	$10,776.00
All-time high date	2019-09-23
All-time low	$2.22
All-time low date	2026-10-27
Average true range (ATR)	$0.98
Average volume	156.4K
Beta (1Y)	0.72
Beta (2Y)	0.53
Beta (5Y)	1.41
Change from 52-week high	-99.4%
Change from 52-week low	17.38%
Change from all-time high	-99.98%
Change from all-time low	17.7%
Change from open	-1.52%
Day's gap	-2.22%
Dollar volume	$90,324
High price	$2.64
Low price	$2.59
Monthly RSI	31.78
Open price	$2.64
Position in 52-week range	20%
Premarket change	0.74%
Premarket close	$2.70
Premarket price	$2.72
Premarket volume	7.7K
Previous close	$2.70
Price vs 150-day SMA	-97.43%
Price vs 20-day SMA	-34.43%
Price vs 200-day SMA	-98.16%
Price vs 50-day SMA	-77.35%
Relative volume	0.22
RSI	14.36
Sharpe ratio	-4.13
Sharpe ratio (3Y)	-1.14
Sharpe ratio (5Y)	-1.12
Sortino ratio	-4.58
Sortino ratio (3Y)	-1.46
Sortino ratio (5Y)	-1.44
Volume	34.7K
Weekly RSI	19.44
YTD price change	-98.46%
YTD total return	-98.46%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	485.3K
Float percentage	39%
Shares change (QoQ)	7.64%
Shares change (YoY)	649.71%
Shares held by insiders	2.45%
Shares held by institutions	9.36%
Shares outstanding	1.2M
Short % of shares	0.5%
Short ratio	0.2 days

Deeper analysis on ENLV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ENLV report

Is a complete ENLV research report available?

No complete published report is available for Enlivex Ltd. (ENLV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Enlivex Ltd. (ENLV)

Price

Financial snapshot

Fair-value bridge

Latest news · ENLV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ENLV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ENLV

Frequently asked questions